Stock Analysis on Net
Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Cash Flow Statement
Quarterly Data

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Medtronic PLC, consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel LibreOffice Calc
3 months ended: Apr 24, 2020 Jan 24, 2020 Oct 25, 2019 Jul 26, 2019 Apr 26, 2019 Jan 25, 2019 Oct 26, 2018 Jul 27, 2018 Apr 27, 2018 Jan 26, 2018 Oct 27, 2017 Jul 28, 2017 Apr 28, 2017 Jan 27, 2017 Oct 28, 2016 Jul 29, 2016 Apr 29, 2016 Jan 29, 2016 Oct 30, 2015 Jul 31, 2015 Apr 24, 2015 Jan 23, 2015 Oct 24, 2014 Jul 25, 2014
Net income (loss) 639  1,919  1,371  877  1,182  1,271  1,120  1,077  1,465  (1,392) 2,013  1,009  1,164  820  1,111  929  1,103  1,095  520  820  (1) 977  828  871 
Depreciation and amortization 672  663  671  657  667  675  651  666  664  666  678  636  718  730  732  737  708  715  696  701  677  206  208  215 
Provision for doubtful accounts 32  23  19  25  23  23  17  15  16  16  10  10  13  13  20  10  10 
Deferred income taxes (522) (548) (263) 18  (99) (125) (83) 123  (212) (888) 58  (55) (354) (82) 32  (169) (17) (115) (159) (906) 41  (159) 98 
Stock-based compensation 62  66  108  61  62  60  104  64  74  72  106  92  76  82  111  79  84  82  113  96  324  33  48  34 
Loss on debt extinguishment —  —  —  406  457  —  —  —  38  —  —  —  —  —  —  —  163  —  —  —  —  —  —  — 
Gain on sale of businesses —  —  —  —  —  —  —  —  —  —  (697) —  —  —  —  —  —  —  —  —  —  —  —  — 
Investment loss —  —  —  —  —  —  —  —  —  227  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Other, net 77  21  61  58  146  56  52  61  53  (36) (5) (55) (83) 15  (31) (48) 200  601  (23) (7)
Accounts receivable, net 1,410  (158) (280) 319  (441) (103) (175) 138  (294) 87  20  (88) (93) 107  (285) 196  (521) 87  (280) 279  (353) (158) 94 
Inventories, net (231) (79) (145) (122) 93  (55) (132) (180) 126  (45) (109) (164) 34  (74) (86) (101) 202  (62) (119) (207) (37) (75) (74) (96)
Accounts payable and accrued liabilities (147) 397  335  (629) 188  187  (61) 85  52  320  85  (392) 324  338  (8) (298) (261) 387  11  (516) 953  670  150  (924)
Other operating assets and liabilities (542) 103  (10) (160) (191) 66  (330) (169) (1,287) 2,210  (275) (419) (410) 420  25  50  (4) (472) 481  (408) 644  (74) 56  17 
Change in operating assets and liabilities, net of acquisitions and divestitures 490  263  (100) (592) (351) 95  (698) (126) (1,403) 2,572  (279) (1,063) (145) 791  (354) (153) (584) (60) 93  (852) 1,207  525  (26) (909)
Adjustments to reconcile net income (loss) to net cash provided by operating activities 811  488  496  633  905  784  43  625  (427) 3,394  (1,106) (272) 609  1,265  361  621  223  702  759  (4) 1,913  790  85  (561)
Net cash provided by operating activities 1,450  2,407  1,867  1,510  2,087  2,055  1,163  1,702  1,038  2,002  907  737  1,773  2,085  1,472  1,550  1,326  1,797  1,279  816  1,912  1,767  913  310 
Acquisitions, net of cash acquired (289) (56) (145) (212) (1,496) (15) (104) (26) (35) (76) —  (22) (1,294) (12) (81) (135) (818) (179) (14,273) (33) (432) (146)
Proceeds from sale of businesses —  —  —  —  —  —  —  —  —  —  6,058  —  —  —  —  —  —  —  —  —  —  —  —  — 
Additions to property, plant, and equipment (336) (293) (283) (301) (335) (302) (206) (291) (292) (252) (246) (278) (330) (326) (268) (330) (353) (247) (222) (224) (255) (106) (101) (109)
Purchases of investments (2,790) (4,023) (2,557) (1,669) (545) (543) (462) (982) (721) (794) (1,070) (615) (1,017) (1,244) (1,066) (1,044) (897) (1,139) (1,519) (1,851) (2,255) (2,303) (1,424) (1,600)
Sales and maturities of investments 3,783  2,531  1,691  1,569  524  1,335  804  2,020  1,167  706  1,383  971  1,070  661  2,521  1,104  5,907  1,265  1,486  1,266  1,539  1,686  812  1,853 
Other investing activities (3) (18) (11) (5) 39  (3) —  —  (17) (3) (7) (11) 34  (2) (3) (15) 29  66  (2) (4)
Net cash (used in) provided by investing activities 365  (1,801) (1,216) (551) (529) (1,009) 121  643  111  (378) 6,042  83  (272) (942) (73) (284) 4,573  (254) (1,088) (986) (15,215) (690) (1,147) (6)
Change in current debt obligations, net (34) (25) (46) 88  (17) (195) (505) 142  (201) (759) 569  (212) (36) 228  926  (1,216) (54) 848  429  (8) (1,604) 749  862 
Proceeds from short-term borrowings, maturities greater than 90 days —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  —  — 
Issuance of long-term debt —  —  5,567  7,791  —  —  18  2,009  —  98  33  —  —  —  —  3,024  16,918  —  — 
Payments on long-term debt (504) (12) (559) (5,035) (7,919) (12) (5) (12) (3,203) (6) (4,153) (8) (502) (109) (235) (17) (3,520) (4) (604) (1,004) (1,255) (6) (4) (3)
Dividends to shareholders (724) (723) (723) (724) (671) (671) (674) (677) (624) (623) (622) (625) (594) (590) (593) (599) (531) (533) (537) (538) (435) (300) (298) (304)
Issuance of ordinary shares 77  153  222  210  101  91  350  450  70  103  87  143  119  49  46  214  131  97  165  98  172  165  158  154 
Repurchase of ordinary shares (118) (246) (629) (333) (149) (681) (1,223) (824) (207) (76) (655) (1,233) (135) (615) (1,031) (1,763) (660) (710) (710) (750) (300) —  (555) (1,065)
Other financing activities (7) (20) (7) (47) (1) 16  (5) (6) (47) (36) (5) (18) (4) 46  (70) 52  57  21  (47) (248) 178 
Net cash provided by (used in) financing activities (1,310) (873) (1,741) (274) (860) (1,268) (1,730) (1,573) (3,828) (849) (6,136) (1,141) 687  (1,319) (1,491) (1,160) (5,866) (1,152) (781) (1,744) 1,151  14,925  228  (355)
Effect of exchange rate changes on cash and cash equivalents (74) 14  (28) (8) 14  (23) (61) (10) 54  25  45  11  (10) (14) 78  122  (48) (11) 50  (236) (58) (43) (16)
Net change in cash and cash equivalents 431  (253) (1,118) 687  690  (208) (469) 711  (2,689) 829  838  (276) 2,199  (186) (106) 184  155  343  (601) (1,864) (12,388) 15,944  (49) (67)

Based on: 10-K (filing date: 2020-06-19), 10-Q (filing date: 2020-02-28), 10-Q (filing date: 2019-12-03), 10-Q (filing date: 2019-08-30), 10-K (filing date: 2019-06-21), 10-Q (filing date: 2019-03-01), 10-Q (filing date: 2018-11-29), 10-Q (filing date: 2018-08-31), 10-K (filing date: 2018-06-22), 10-Q (filing date: 2018-03-02), 10-Q (filing date: 2017-12-04), 10-Q (filing date: 2017-09-01), 10-K (filing date: 2017-06-27), 10-Q (filing date: 2017-03-03), 10-Q (filing date: 2016-12-05), 10-Q (filing date: 2016-09-07), 10-K (filing date: 2016-06-28), 10-Q (filing date: 2016-03-09), 10-Q (filing date: 2015-12-09), 10-Q (filing date: 2015-09-09), 10-K (filing date: 2015-06-23), 10-Q (filing date: 2015-02-27), 10-Q (filing date: 2014-11-26), 10-Q (filing date: 2014-08-29).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Medtronic PLC’s net cash provided by operating activities increased from Q2 2020 to Q3 2020 but then decreased significantly from Q3 2020 to Q4 2020.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Medtronic PLC’s net cash (used in) provided by investing activities decreased from Q2 2020 to Q3 2020 but then increased from Q3 2020 to Q4 2020 exceeding Q2 2020 level.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Medtronic PLC’s net cash provided by (used in) financing activities increased from Q2 2020 to Q3 2020 but then slightly decreased from Q3 2020 to Q4 2020 not reaching Q2 2020 level.